LINC01413

Across TCGA pan-cancer cohorts, LINC01413 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01413’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01413 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01413 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, KICH, and UCEC are the cancer types where LINC01413 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01413 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	−0.051	.003	7	view →
KICH	All	All	−0.042	.012	3	view →
UCEC	All	IV	−0.235	.004	2	view →
THCA	All	All	−0.066	.037	1	view →
LIHC	All	III,IV	+0.028	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01413–KIRC

Open the KIRC breakdown →